Telogen effluvium x female pattern hair loss: is there correlation?

Mulinari‐Brenner, Fabiane; Oldoni, Carolina

doi:10.1590/abd1806-4841.20198427

Cited by 5 publications

(6 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…TE has been known to cause an unmasking of underlying androgenic alopecia or female pattern hair loss [9, 10]. In a recent study, 12 of 16 patients with postpartum TE were diagnosed with female pattern hair loss 1 year later [9]. Here, we report a case series of postpartum TE unmasking TA.…”

Section: Introduction/literature Reviewmentioning

confidence: 90%

See 1 more Smart Citation

Postpartum Telogen Effluvium Unmasking Traction Alopecia

Samrao

Mirmirani

2022

Skin Appendage Disord

View full text Add to dashboard Cite

Introduction: Telogen effluvium (TE) is a type of diffuse hair shedding that occurs 2–3 months after an exposure or trigger. The excessive hair loss may “unmask” underlying hair loss disorders such as female pattern hair loss. Case Presentation: This is a case series of 3 patients with postpartum TE in which an underlying traction alopecia (TA) was revealed. Conclusion: TE can unmask underlying TA. Awareness of this phenomenon is critical to appropriate diagnosis and treatment.

show abstract

Section: Introduction/literature Reviewmentioning

confidence: 90%

“…It typically presents months to years after prolonged tension on the hair follicles [4][5][6][7][8]. TE has been known to cause an unmasking of underlying androgenic alopecia or female pattern hair loss [9,10]. In a recent study, 12 of 16 patients with postpartum TE were diagnosed with female pattern hair loss 1 year later [9].…”

mentioning

confidence: 99%

Postpartum Telogen Effluvium Unmasking Traction Alopecia

Samrao

Mirmirani

2022

Skin Appendage Disord

View full text Add to dashboard Cite

show abstract

“…Clinically, TE presents similarly to FPHL with diffuse hair loss and widening of the mid‐frontal central hair parting line. However, clumps of hair falling out while showering is indicative of TE, as isa positive pull test, as opposed to FPHL which usually shows a negative pull test 23,24 . Frontal fibrosing alopecia (FFA) is an inflammatory fibrosing hair loss that is evident as frontal hairline regression.…”

Section: Differential Diagnosesmentioning

confidence: 99%

Female pattern hair loss: A comprehensive review

Bertoli

Sadoughifar

Schwartz

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

Female pattern hair loss is a common form of hair loss in women that increases in incidence with age. The etiology is unknown with numerous factors identified that influence its onset. Female pattern hair loss may be viewed as a marker for an increased risk of cardiovascular and metabolic disease. New treatments include microneedling, low-level laser therapy, and autologous fat transfer. This article focuses on the pathophysiology, diagnosis, systemic associations, and current treatments for female pattern hair loss, which is the most common cause of alopecia in women.

show abstract

“…По данным бразильского исследования, роды стали провоцирующим фактором потери волос для 38,1% пациенток, прием лекарственных средств (антидепрессантов или противосудорожных препаратов) -28,6%, диагностирование нового заболевания -23,8%, хирургические операции -9,5%. У 75% пациенток, чье состояние было связано с рождением ребенка, поредение волос не прекратилось даже спустя год после родов [6]. Пусть роды и являются естественным событием для женского организма, для многих женщин деторождение становится также и стрессовым фактором.…”

Section: причины диффузного поредения волосunclassified

Diffuse hair loss in women: causes and therapeutic approach

2020

View full text Add to dashboard Cite

Throughout human history, women have paid great attention to the beauty of their hair, and modern women are no exception. About 63% of young American women use different nutritional supplements to prevent hair loss. Diffuse hair loss is quite common in women and can occur against the background of various events: pregnancy, pre- and post-menopause, chronic diseases, etc. The most common is telogen effluvium (TE), which begins 2-3 months after the trigger event. Usually, TE process stops on its own, but can also become chronic. For many women, pregnancy and associated psycho-emotional stress become the triggering event, and in 75% of cases hair loss can become chronic.In fact, TE is a violation of the hair growth cycle. First of all, it is necessary to exclude the trigger factor from the patient's life and only then to start normalizing the hair growth cycle and improve the quality of hair follicle nutrition. The most effective topical remedy for the treatment of diffuse hair loss is minoxidil. The reasons for its clinical effectiveness have not been fully studied, but it is known that it prolongs the hair growth phase. Unfortunately, after cancellation of the drug, hair loss is often renewed. Avoiding these effects is possible with a comprehensive approach to therapy. Inclusion of additional components in the therapy scheme, such as vitamin and mineral complexes, growth stimulants, specialized care products, allows to maintain and improve the results of treatment with minoxidil.

show abstract

Telogen effluvium x female pattern hair loss: is there correlation?

Cited by 5 publications

References 5 publications

Postpartum Telogen Effluvium Unmasking Traction Alopecia

Postpartum Telogen Effluvium Unmasking Traction Alopecia

Female pattern hair loss: A comprehensive review

Diffuse hair loss in women: causes and therapeutic approach

Contact Info

Product

Resources

About